Pet Genetic Test Kits Market - Global Forecast 2025-2032

The Pet Genetic Test Kits Market continues to evolve as organizations pursue reliable, data-driven tools to streamline operations and better respond to consumer expectations for advanced animal healthcare. Senior decision-makers are increasingly interested in leveraging emerging trends and technologies to enhance differentiation and long-term value in the companion animal sector.

Market Snapshot: Pet Genetic Test Kits Market Growth and Dynamics

The Pet Genetic Test Kits Market achieved notable expansion, advancing from USD 386.42 million in 2024 to USD 426.39 million in 2025. Forecasts indicate a compound annual growth rate (CAGR) of 10.42%, with total market value projected to reach USD 853.98 million by 2032. Growth is driven by a measurable shift toward preventive veterinary care, the adoption of pioneering genetic sequencing technology, and heightened consumer awareness of pet wellness. The rise of direct-to-consumer distribution models is lowering access barriers, giving pet owners a proactive role in pet health management. Regional factors play a significant role, with veterinary professionals and distributors spurring adoption across markets at different stages of maturity.

Scope & Segmentation

This report offers senior leaders actionable analysis on the primary factors shaping the Pet Genetic Test Kits Market, enabling precise alignment of investments and resources throughout the value chain.

• Pet Types: Explores both cat and dog genetic diagnostics to match core demand for companion animal testing solutions.
• Test Types: Includes breed identification, genetic disease screening, and trait analysis for use cases ranging from ancestry verification to detection of inherited conditions and wellness-related markers.
• Distribution Channels: Analyzes online retailers, pet specialty stores, and veterinary clinics, highlighting evolving buyer preferences and shifts in delivery models.
• Technology: Examines next generation sequencing for detailed diagnostics and PCR-based technologies for accessible, cost-effective applications in clinical or home settings.
• End Users: Considers pet owners seeking direct insights, research organizations focused on genetic studies, and veterinary laboratories that support advanced screening and clinical diagnosis.
• Geographic Regions: Provides full coverage of the Americas, Europe, Middle East & Africa, and Asia-Pacific, showing variations in market maturity, pet ownership rates, and local care approaches.
• Major Companies: Assesses key players including Mars, Incorporated; Embark Veterinary, Inc.; Neogen Corporation; Animal Genetics, Inc.; Basepaws, Inc.; Orivet Innovations Pty Ltd; Paw Print Genetics, LLC; DNA My Dog, LLC; AlphaBiolabs Limited; and GenSol Diagnostics, Inc. with a focus on strategic positioning and competition.

Key Takeaways for Senior Decision-Makers

• Genetic testing is facilitating a shift in animal healthcare, supporting more precise interventions and earlier detection of genetic conditions.
• Increased direct-to-consumer availability empowers pet owners and drives greater engagement in preventive care and wellness monitoring.
• Partnerships among biotech firms, e-commerce platforms, and research entities are elevating data integration and setting new standards for test result delivery within digital veterinary ecosystems.
• North America remains the most established regional market with a mature framework, while Asia-Pacific and EMEA regions exhibit strong growth potential from rising pet ownership and advancing technology.
• Strategic selection of diagnostic technologies—such as next generation sequencing for comprehensive analysis or PCR for practical, accessible testing—enables providers to differentiate and address diverse client needs.

Tariff Impact on the Pet Genetic Testing Sector

In 2025, newly introduced tariffs in the United States raised procurement costs for critical reagents and sequencing components within the pet genetic testing segment. Industry participants responded by diversifying their supply chains and renegotiating with regional vendors, effectively reducing vulnerability to short-term price volatility. These operational adjustments created new pricing frameworks and encouraged greater resilience in domestic supply logistics. Companies aligning their sourcing and production strategies with these developments have positioned themselves to maintain competitive agility and adapt swiftly to ongoing fluctuations.

Methodology & Data Sources

The report relies on a mixed-methods research model. Secondary data sources include patent activity, published scientific research, and regulatory documentation. Insights are further strengthened by primary interviews across the market value chain, and results are validated using focused surveys and expert review to ensure the relevance and reliability of every data point presented.

Why This Report Matters

• Provides senior leaders with the facts and analysis required for informed, strategic investments in emerging animal health opportunities.
• Enables organizations to build resilience in the face of shifting regulatory, supply chain, and technological factors while supporting expansion into promising new geographies.
• Equips stakeholders to fine-tune their product and technology strategies, fostering sustainable competitive advantage in key market segments.

Conclusion

Ongoing advancements in genetic testing and evolving consumer priorities are transforming the Pet Genetic Test Kits Market. Organizations that invest strategically and adapt to these changes are more likely to secure long-term growth and competitive strength across core and expanding markets.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.